Resultats de la cerca - Parissa Tabrizian

Refinar resultats
  1. 1
    Current management of hepatocellular carcinoma

    Current management of hepatocellular carcinoma per Parissa Tabrizian

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    PD-1 inhibitor as bridge therapy to liver transplantation?

    PD-1 inhibitor as bridge therapy to liver transplantation? per Parissa Tabrizian, Sander Florman, Myron Schwartz

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  3. 3
    Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data

    Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data per Charles‐Henri Wassmer, Sofia El Hajji, Xenofon Papazarkadas, Philippe Compagnon, Parissa Tabrizian, Stéphanie Lacotte, Christian Toso

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma

    Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma per Ismaïl Labgaa, Parissa Tabrizian, J. Titano, Edward Kim, Swan N. Thung, Sander Florman, Myron Schwartz, Emmanuel Melloul

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly

    Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly per Parissa Tabrizian, Ghalib Jibara, Brian Shrager, Bernardo Franssen, Ming‐Jim Yang, Umut Sarpel, Spiros P. Hiotis, Daniel M. Labow

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Outcomes following resection of intrahepatic cholangiocarcinoma

    Outcomes following resection of intrahepatic cholangiocarcinoma per Parissa Tabrizian, Ghalib Jibara, Jaclyn F. Hechtman, Bernardo Franssen, Daniel M. Labow, Myron Schwartz, Swan N. Thung, Umut Sarpel

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: A multi‐institutional analysis

    Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: A multi‐institutional analysis per Parissa Tabrizian, Thejus Jayakrishnan, Anthony J. Zacharias, Samantha N. Aycart, Fabian M. Johnston, Umut Sarpel, Daniel M. Labow, Kiran K. Turaga

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)

    Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020) per Philipp K. Haber, Marc Puigvehí, Florian Castet, Vennis Lourdusamy, Robert Montal, Parissa Tabrizian, Michael Buckstein, Edward Kim, Augusto Villanueva, Myron Schwartz, Josep M. Llovet

    Publicat 2021
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria

    Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria per F. D’Amico, Myron Schwartz, Alessandro Vitale, Parissa Tabrizian, Sasan Roayaie, Swan N. Thung, Maria Guido, Juan Del Rio Martin, Thomas D. Schiano, Umberto Cillo

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma

    European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma per Marco P. A. W. Claasen, Dimitri Sneiders, Yannick S. Rakké, René Adam, Sherrie Bhoori, Umberto Cillo, Constantino Fondevila, María Reig, Gonzalo Sapisochín, Parissa Tabrizian, Christian Toso

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma

    High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma per Delia D’Avola, Carlos Villacorta-Martín, Sebastiao N. Martins‐Filho, Amanda J. Craig, Ismaïl Labgaa, Johann von Felden, Kimaada Allette, Antoinette Bonaccorso, Parissa Tabrizian, Boris Hartmann, Robert Sebra, Myron Schwartz, Augusto Villanueva

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades

    Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades per Marc Puigvehí, Dana Hashim, Philipp K. Haber, Amreen Dinani, Thomas D. Schiano, Amon Asgharpour, Tatyana Kushner, Gaurav Kakked, Parissa Tabrizian, Myron Schwartz, Ahmet Gürakar, Douglas T. Dieterich, Paolo Boffetta, Scott L. Friedman, Josep M. Llovet, Behnam Saberi

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium

    Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium per Neil Mehta, Catherine Frenette, Parissa Tabrizian, Maarouf Hoteit, Jennifer Guy, Neehar D. Parikh, Tahereh Ghaziani, Renumathy Dhanasekaran, Jennifer L. Dodge, Brahma Natarajan, Matthew L. Holzner, Leana Frankul, Wesley Chan, Austin J. Fobar, Sander Florman, Francis Y. Yao

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management—Guidelines From the ILTS-SETH Consensus Conference

    De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management—Guidelines From the ILTS-SETH Consensus Conference per Jordi Colmenero, Parissa Tabrizian, Prashant Bhangui, David J. Pinato, Manuel Rodríguez‐Perálvarez, Gonzalo Sapisochín, Sherrie Bhoori, Sonia Pascual, Marco Senzolo, David Al‐Adra, J.I. Herrero, Henrik Petrowsky, Laura A. Dawson, Ali Hosni, Jade L. Kutzke, Mikel Gastaca, Kymberly D. Watt

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Predicting futile outcomes following deceased donor liver transplantation in non-Hcc patients with MELD-Na score above 30: a retrospective international multicenter cohort study

    Predicting futile outcomes following deceased donor liver transplantation in non-Hcc patients with MELD-Na score above 30: a retrospective international multicenter cohort study per Hye-Sung Jo, In‐Young Yoon, Ki-Hun Kim, Parissa Tabrizian, Rebecca Marino, Pedro Marin-Castro, Wellington Andraus, Jong Man Kim, Gyu-Seong Choi, Deok Gie Kim, Dong Jin Joo, Carlos Florez-Zorrilla, Deniz Balcı, Henrik Petrowsky, Karim J. Halazun, Dong‐Sik Kim

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma

    Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma per Parissa Tabrizian, Matthew L. Holzner, Neil Mehta, Karim J. Halazun, Vatche G. Agopian, Francis Y. Yao, Ronald W. Busuttil, John P. Roberts, Jean C. Emond, Benjamin Samstein, Robert S. Brown, Marc Najjar, William C. Chapman, Majella M.B. Doyle, Sander Florman, Myron Schwartz, Josep M. Llovet

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development

    Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development per Xiaochen Wang, Qifeng He, Chuanli Zhou, Yueyuan Xu, Danhui Liu, Naoto Fujiwara, Naoto Kubota, Arielle Click, Polly Henderson, Janiece Vancil, Cesia A. Marquez, Ganesh Gunasekaran, Myron Schwartz, Parissa Tabrizian, Umut Sarpel, Maria Isabel Fiel, Yarui Diao, Beicheng Sun, Yujin Hoshida, Shuang Liang, Zhenyu Zhong

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

    A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma per Ismaïl Labgaa, Carlos Villacorta-Martín, Delia D’Avola, Amanda J. Craig, Johann von Felden, Sebastiao N. Martins‐Filho, Daniela Sia, Ashley Stueck, Stephen C. Ward, Maria Isabel Fiel, Milind Mahajan, Parissa Tabrizian, Swan N. Thung, Celina Ang, Scott L. Friedman, Josep M. Llovet, Myron Schwartz, Augusto Villanueva

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion – a multi‐center retrospective cohort study

    Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion – a multi‐center retrospective cohort study per Michela Assalino, Sylvain Terraz, Michał Grąt, Quirino Lai, Neeta Vachharajani, Enrico Gringeri, Marco Bongini, Laura Kulik, Parissa Tabrizian, Vatche G. Agopian, Neil Mehta, Raffaele Brustia, Giulio Cesare Vitali, Axel Andrès, Thierry Berney, Vincenzo Mazzaferro, Philippe Compagnon, Pietro Majno, Umberto Cillo, William C. Chapman, Krzysztof Zieniewicz, Olivier Scatton, Christian Toso

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma

    Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma per Karim J. Halazun, Russell Rosenblatt, Neil Mehta, Quirino Lai, Kaveh Hajifathalian, Andre Gorgen, Gagan Brar, Kazunari Sasaki, Maria B. Majella Doyle, Parissa Tabrizian, Vatche G. Agopian, Marc Najjar, Tommy Ivanics, Benjamin Samstein, Robert S. Brown, Jean C. Emond, Francis Y. Yao, Jan Lerut, Massimo Rossi, Gianluca Mennini, Samuele Iesari, Armin Finkenstedt, Benedikt Schaefer, J Mittler, Maria Hoppe‐Lotichius, Cristiano Quintini, Federico Aucejo, William C. Chapman, Gonzalo Sapisochín

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: